Breast cancer can form 'sleeper cells' after drug treatment

Breast cancer medicines may force some cancer cells into 'sleeper mode,' allowing them to potentially come back to life years after initial treatment.

from Women's Health News -- ScienceDaily https://ift.tt/2ZuXz06

Breast cancer can form 'sleeper cells' after drug treatment

Breast cancer medicines may force some cancer cells into 'sleeper mode,' allowing them to potentially come back to life years after initial treatment.

from Women's Health News -- ScienceDaily https://ift.tt/2ZuXz06

Breast cancer can form 'sleeper cells' after drug treatment

Breast cancer medicines may force some cancer cells into 'sleeper mode,' allowing them to potentially come back to life years after initial treatment.

from Breast Cancer News -- ScienceDaily https://ift.tt/2ZuXz06

Menopausal hormone therapy and breast cancer incidence

New research suggest that all types of MHT, except topical vaginal estrogens, are associated with increased risks of breast cancer, and that the risks are greater for users of estrogen-progestagen hormone therapy than for estrogen-only hormone therapy. For estrogen-progestagen therapy, the risks were greater if the progestagen was included daily rather than intermittently (eg, for 10-14 days per month).

from Breast Cancer News -- ScienceDaily https://ift.tt/2ZFZvOm

Menopausal hormone therapy and breast cancer incidence

New research suggest that all types of MHT, except topical vaginal estrogens, are associated with increased risks of breast cancer, and that the risks are greater for users of estrogen-progestagen hormone therapy than for estrogen-only hormone therapy. For estrogen-progestagen therapy, the risks were greater if the progestagen was included daily rather than intermittently (eg, for 10-14 days per month).

from Women's Health News -- ScienceDaily https://ift.tt/2ZFZvOm

Menopausal hormone therapy and breast cancer incidence

New research suggest that all types of MHT, except topical vaginal estrogens, are associated with increased risks of breast cancer, and that the risks are greater for users of estrogen-progestagen hormone therapy than for estrogen-only hormone therapy. For estrogen-progestagen therapy, the risks were greater if the progestagen was included daily rather than intermittently (eg, for 10-14 days per month).

from Women's Health News -- ScienceDaily https://ift.tt/2ZFZvOm

Waist size, not body mass index, may be more predictive of coronary artery disease

For years, women have been told that weight gain could lead to heart disease. A new study indicates that it is the location of the fat that matters most, with abdominal fat representing the greatest harm and not overall body mass index (BMI) when assessing risk for coronary artery disease (CAD).

from Women's Health News -- ScienceDaily https://ift.tt/2PjpDyV

Waist size, not body mass index, may be more predictive of coronary artery disease

For years, women have been told that weight gain could lead to heart disease. A new study indicates that it is the location of the fat that matters most, with abdominal fat representing the greatest harm and not overall body mass index (BMI) when assessing risk for coronary artery disease (CAD).

from Women's Health News -- ScienceDaily https://ift.tt/2PjpDyV

Mechanism inducing self-killing of cancer cells

A research team has developed helical polypeptide potassium ionophores that lead to the onset of programmed cell death.

from Women's Health News -- ScienceDaily https://ift.tt/32ccZmy

Mechanism inducing self-killing of cancer cells

A research team has developed helical polypeptide potassium ionophores that lead to the onset of programmed cell death.

from Women's Health News -- ScienceDaily https://ift.tt/32ccZmy